219 related articles for article (PubMed ID: 12021307)
1. Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes.
Haque MA; Li P; Jackson SK; Zarour HM; Hawes JW; Phan UT; Maric M; Cresswell P; Blum JS
J Exp Med; 2002 May; 195(10):1267-77. PubMed ID: 12021307
[TBL] [Abstract][Full Text] [Related]
2. Reduced immunogenicity of Plasmodium falciparum gamete surface antigen (Pfs48/45) in mice after disruption of disulphide bonds - evaluating effect of interferon-γ-inducible lysosomal thiol reductase.
Merino KM; Bansal GP; Kumar N
Immunology; 2016 Aug; 148(4):433-47. PubMed ID: 27177843
[TBL] [Abstract][Full Text] [Related]
3. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma.
Nguyen J; Bernert R; In K; Kang P; Sebastiao N; Hu C; Hastings KT
Melanoma Res; 2016 Apr; 26(2):125-37. PubMed ID: 26930048
[TBL] [Abstract][Full Text] [Related]
4. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition.
Haque MA; Hawes JW; Blum JS
J Immunol; 2001 Apr; 166(7):4543-51. PubMed ID: 11254711
[TBL] [Abstract][Full Text] [Related]
5. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.
Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A
Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923
[TBL] [Abstract][Full Text] [Related]
6. GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.
Rausch MP; Meador LR; Metzger TC; Li H; Qiu S; Anderson MS; Hastings KT
J Immunol; 2020 Jun; 204(11):2877-2886. PubMed ID: 32269095
[TBL] [Abstract][Full Text] [Related]
7. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent.
O'Donnell PW; Haque A; Klemsz MJ; Kaplan MH; Blum JS
J Immunol; 2004 Jul; 173(2):731-5. PubMed ID: 15240658
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers.
Janjic B; Andrade P; Wang XF; Fourcade J; Almunia C; Kudela P; Brufsky A; Jacobs S; Friedland D; Stoller R; Gillet D; Herberman RB; Kirkwood JM; Maillere B; Zarour HM
J Immunol; 2006 Aug; 177(4):2717-27. PubMed ID: 16888034
[TBL] [Abstract][Full Text] [Related]
10. Diverse cellular and organismal functions of the lysosomal thiol reductase GILT.
Rausch MP; Hastings KT
Mol Immunol; 2015 Dec; 68(2 Pt A):124-8. PubMed ID: 26116226
[TBL] [Abstract][Full Text] [Related]
11. MHC class II-restricted presentation of the major house dust mite allergen Der p 1 Is GILT-dependent: implications for allergic asthma.
West LC; Grotzke JE; Cresswell P
PLoS One; 2013; 8(1):e51343. PubMed ID: 23326313
[TBL] [Abstract][Full Text] [Related]
12. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.
Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C
J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037
[TBL] [Abstract][Full Text] [Related]
13. Antigen-presenting cells and the selection of immunodominant epitopes.
Blum JS; Ma C; Kovats S
Crit Rev Immunol; 1997; 17(5-6):411-7. PubMed ID: 9419428
[TBL] [Abstract][Full Text] [Related]
14. Defective antigen processing in GILT-free mice.
Maric M; Arunachalam B; Phan UT; Dong C; Garrett WS; Cannon KS; Alfonso C; Karlsson L; Flavell RA; Cresswell P
Science; 2001 Nov; 294(5545):1361-5. PubMed ID: 11701933
[TBL] [Abstract][Full Text] [Related]
15. DM determines the cryptic and immunodominant fate of T cell epitopes.
Nanda NK; Sant AJ
J Exp Med; 2000 Sep; 192(6):781-8. PubMed ID: 10993909
[TBL] [Abstract][Full Text] [Related]
16. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.
Sun Y; Sijts AJ; Song M; Janek K; Nussbaum AK; Kral S; Schirle M; Stevanovic S; Paschen A; Schild H; Kloetzel PM; Schadendorf D
Cancer Res; 2002 May; 62(10):2875-82. PubMed ID: 12019167
[TBL] [Abstract][Full Text] [Related]
17. Role of disulfide bonds in regulating antigen processing and epitope selection.
Li P; Haque MA; Blum JS
J Immunol; 2002 Sep; 169(5):2444-50. PubMed ID: 12193713
[TBL] [Abstract][Full Text] [Related]
18. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR
J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775
[TBL] [Abstract][Full Text] [Related]
19. B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway.
Su Y; Carey G; Maric M; Scott DW
J Immunol; 2008 Jul; 181(2):1153-60. PubMed ID: 18606668
[TBL] [Abstract][Full Text] [Related]
20. High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma.
Buetow KH; Meador LR; Menon H; Lu YK; Brill J; Cui H; Roe DJ; DiCaudo DJ; Hastings KT
J Immunol; 2019 Nov; 203(10):2577-2587. PubMed ID: 31591149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
